Degradation of cell proteins and the generation of MHC class I-presented peptides - PubMed (original) (raw)
Review
Degradation of cell proteins and the generation of MHC class I-presented peptides
K L Rock et al. Annu Rev Immunol. 1999.
Abstract
Major histocompatibility complex (MHC) class I molecules display on the cell surface 8- to 10-residue peptides derived from the spectrum of proteins expressed in the cells. By screening for non-self MHC-bound peptides, the immune system identifies and then can eliminate cells that are producing viral or mutant proteins. These antigenic peptides are generated as side products in the continual turnover of intracellular proteins, which occurs primarily by the ubiquitin-proteasome pathway. Most of the oligopeptides generated by the proteasome are further degraded by distinct endopeptidases and aminopeptidases into amino acids, which are used for new protein synthesis or energy production. However, a fraction of these peptides escape complete destruction and after transport into the endoplasmic reticulum are bound by MHC class I molecules and delivered to the cell surface. Herein we review recent discoveries about the proteolytic systems that degrade cell proteins, how the ubiquitin-proteasome pathway generates the peptides presented on MHC-class I molecules, and how this process is stimulated by immune modifiers to enhance antigen presentation.
Similar articles
- Role of proteasomes in antigen presentation.
Gaczynska M, Rock KL, Goldberg AL. Gaczynska M, et al. Enzyme Protein. 1993;47(4-6):354-69. doi: 10.1159/000468693. Enzyme Protein. 1993. PMID: 7697133 Review. - Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.
Gaczynska M, Rock KL, Goldberg AL. Gaczynska M, et al. Nature. 1993 Sep 16;365(6443):264-7. doi: 10.1038/365264a0. Nature. 1993. PMID: 8396732 - Proteolysis and class I major histocompatibility complex antigen presentation.
York IA, Goldberg AL, Mo XY, Rock KL. York IA, et al. Immunol Rev. 1999 Dec;172:49-66. doi: 10.1111/j.1600-065x.1999.tb01355.x. Immunol Rev. 1999. PMID: 10631936 Review. - Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules.
Shastri N, Schwab S, Serwold T. Shastri N, et al. Annu Rev Immunol. 2002;20:463-93. doi: 10.1146/annurev.immunol.20.100301.064819. Epub 2001 Oct 4. Annu Rev Immunol. 2002. PMID: 11861610 - Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
Rock KL, York IA, Goldberg AL. Rock KL, et al. Nat Immunol. 2004 Jul;5(7):670-7. doi: 10.1038/ni1089. Nat Immunol. 2004. PMID: 15224092 Review.
Cited by
- The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated.
Jallow S, Leligdowicz A, Kramer HB, Onyango C, Cotten M, Wright C, Whittle HC, McMichael A, Dong T, Kessler BM, Rowland-Jones SL. Jallow S, et al. Eur J Immunol. 2015 Aug;45(8):2232-42. doi: 10.1002/eji.201545451. Epub 2015 Jun 24. Eur J Immunol. 2015. PMID: 26018465 Free PMC article. - ProEnd: a comprehensive database for identifying HbYX motif-containing proteins across the tree of life.
Salcedo-Tacuma D, Howells GD, McHose C, Gutierrez-Diaz A, Schupp J, Smith DM. Salcedo-Tacuma D, et al. BMC Genomics. 2024 Oct 13;25(1):951. doi: 10.1186/s12864-024-10864-4. BMC Genomics. 2024. PMID: 39396964 Free PMC article. - The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
Hotta C, Fujimaki H, Yoshinari M, Nakazawa M, Minami M. Hotta C, et al. Immunology. 2006 Jan;117(1):97-107. doi: 10.1111/j.1365-2567.2005.02270.x. Immunology. 2006. PMID: 16423045 Free PMC article. - Combining radiotherapy and immunotherapy: a revived partnership.
Demaria S, Bhardwaj N, McBride WH, Formenti SC. Demaria S, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):655-66. doi: 10.1016/j.ijrobp.2005.06.032. Int J Radiat Oncol Biol Phys. 2005. PMID: 16199306 Free PMC article. Review. - Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines.
Leachman SA, Shylankevich M, Slade MD, Levine D, Sundaram RK, Xiao W, Bryan M, Zelterman D, Tiegelaar RE, Brandsma JL. Leachman SA, et al. J Virol. 2002 Aug;76(15):7616-24. doi: 10.1128/jvi.76.15.7616-7624.2002. J Virol. 2002. PMID: 12097575 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials